Cofactor Genomics

Cofactor Genomics is a biotechnology company focused on advancing precision medicine through predictive immune modeling. The company aims to overcome challenges in the field by transitioning from traditional single-analyte biomarkers to more comprehensive multidimensional biomarkers, utilizing their Health Expression Models. Cofactor Genomics offers a suite of molecular, informatic, and database tools, along with a CAP-certified clinical RNA sequencing laboratory. This enables partners in the biotechnology sector to conduct more efficient and cost-effective clinical trials. The company's platform specifically analyzes RNA biomarkers linked to responses to targeted therapeutics, facilitating the development of clinical diagnostic assays for oncologic, immunologic, and neurodegenerative diseases.

Jarret Glasscock

Co-Founder, CEO and Board Member

David Messina Ph.D

Co-Founder and COO

1 past transactions

Narus Biotechnologies

Acquisition in 2016
Narus Biotechnologies uses cell free RNA to monitor neurodegeneration. It develops novel molecular diagnostics for cancer and neurological disease. Narus Biotechnologies is a U.S.-based company that was founded in 2015 by Raman Talwar and Ryan Bloom. The company was acquired by Cofactor Genomics on February 4, 2016.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.